Clin2
NCT07433452Possibly a fitNot yet recruiting

Psilocybin effects on healthy volunteers

Healthy ParticipantsPlacebo - ControlPsilocybin

Treatments studied

This study tests how psilocybin, a psychedelic substance, affects the brain and body in healthy volunteers. It aims to find biological and mental changes that could help future therapies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
50 people
Ages
21 years to 65 years
Study type
Interventional

Who can take part

  • Adults aged 21 to 65
  • No past or current substance use disorder
  • Never or barely used psychedelics or dissociative drugs
  • Healthy heart, blood pressure, and no major medical conditions
  • No family history of serious psychiatric illness
  • Willing to use reliable birth control if female

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07180108Recruiting· Phase 1
Psilocybin and music study for healthy volunteers

This study tests how music affects your experience with psilocybin, a psychedelic substance. It may help researchers understand how to create the best setting for psilocybin therapy.

Baltimore, Maryland
NCT07079852Not yet recruiting· Phase 1/Phase 2
Psilocybin effects on memory and brain function

This study tests how psilocybin, a substance that can cause hallucinations, affects memory and brain activity in healthy adults. It may help us understand how psilocybin could be used for mental health treatments.

Austin, Texas
NCT06772753Recruiting· Phase 1
Study of Psychedelic Effects in Healthy Adults

This study tests how certain psychoactive substances affect your mind and body. It is looking for healthy volunteers to take part in supervised sessions to explore the effects of these drugs.

Baltimore, Maryland
NCT06626139Recruiting· Phase 2
Psilocybin study for healthy volunteers

This trial tests how the setting and context affect the experience of psilocybin, a psychedelic drug. It aims to understand how the environment influences the effects in healthy adults.

San Francisco, California
NCT07565493Recruiting· Early Phase 1
Psilocybin with a serotonin blocker in healthy adults

This early-stage research study tests how psilocybin (a naturally occurring compound from certain mushrooms) works when combined with a medication that blocks a specific serotonin pathway in the brain. Researchers want to understand how these two substances interact in healthy volunteers to inform future psychiatric treatment studies.

Baltimore, Maryland
NCT05301608Recruiting· Phase 1/Phase 2
Psilocybin study of brain activity and changing thoughts

This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.

Baltimore, Maryland

Hear when a new Placebo - Control trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.